Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2005
08/18/2005WO2005074598A2 Nitroxyl progenitor compounds and methods of use
08/18/2005WO2005074387A2 Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
08/18/2005WO2005062992A3 Substituted melatonin derivatives, process for their preparation, and methods of use
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005WO2004026837A3 Histamine h3 receptor antagonists, preparaton and therapeutic uses
08/18/2005US20050182123 5-Fluorooxindole-3-carboxylic acid ester
08/18/2005US20050182121 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050180953 peptides derivatives as an agent inducing cells differentiation and in particular, to their use in antitumor noncytotoxic therapy; melanoma; most preferred compound used in the present invention is 4-[N-(2-imidazol-4-yl)ethyl)carbamoyl]butyric acid (Dicarbamine (reg) )
08/18/2005DE102004001433A1 cis-Alkoxyspiro-substituierte Tetramsäure-Derivate cis-Alkoxyspiro-substituted tetramic acid derivatives
08/18/2005DE10134196B4 Pharmazeutische Zusammensetzung zur Hemmung der unkontrollierten Vermehrung und/oder Induzierung der Apoptose von Zellen A pharmaceutical composition for inhibiting uncontrolled proliferation and / or inducing apoptosis of cells
08/18/2005CA2555453A1 Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents
08/18/2005CA2555313A1 Heparanase inhibitors and uses thereof
08/18/2005CA2554771A1 Nitroxyl progenitor compounds and methods of use
08/18/2005CA2553652A1 Synthesis methods and intermediates for the manufacture of rizatriptan
08/17/2005EP1564215A1 Process for preparing glycidylphthalimide
08/17/2005EP1562943A1 Fused heterocyclic compounds
08/17/2005EP1562900A1 Polymorphs of bicifadine hydrochloride
08/17/2005EP1562899A2 N-(indole-2-carbonyl)amides as anti-diabetic agents
08/17/2005EP1562898A1 Indole derivatives as somatostatin agonists or antagonists
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562891A1 4-aminomethyl-1-aryl-cyclohexylamine derivatives
08/17/2005EP1562584A1 Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1289951B1 Growth hormone secretagogues
08/17/2005EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
08/17/2005EP1202945B1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
08/17/2005CN1656068A Polypeptides and biosynthetic pathways
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215052C Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
08/16/2005US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide
08/16/2005US6930123 Benz(f)indole compounds useful for Inflammatory Diseases
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005CA2342974C Methods and compositions for inhibition of angiogenesis
08/16/2005CA2106642C Carbazolone derivatives and process for preparing the same
08/11/2005WO2005073213A2 Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
08/11/2005WO2005073205A1 Selective estrogen receptor modulators
08/11/2005WO2005073191A1 Hydroisoindoline tachykinin receptor antagonists
08/11/2005WO2005073190A1 Selective estrogen receptor modulators
08/11/2005WO2005073189A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/11/2005WO2005073180A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
08/11/2005WO2005066121A3 Multifunctional amine capture agents
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005040368A3 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004110983A8 New benzamides as pparϒ modulators
08/11/2005US20050176803 Indole derivatives as anti-inflammatory agents
08/11/2005US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/11/2005US20050176797 Thromboembolic disorders; e.g. 2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-5'-fluoro-6,2'-dihydroxy-biphenyl-3-yl]-succinic acid
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
08/11/2005US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation
08/11/2005US20050176730 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligands
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases
08/11/2005US20050175858 Blue light emitter with large triplet energy band gap; color purity, luminescence efficiency. reduced power consumption
08/10/2005EP1561741A1 Method for deuteration or tritiation of heterocyclic ring
08/10/2005EP1561425A1 Indocyanine dyes
08/10/2005EP1560809A1 Cyclohexylurea derivatives
08/10/2005EP1560806A2 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1358168B1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1068306B1 Pentaerythritol lipid derivatives
08/10/2005EP0888301B1 Mcbi analogs of cc-1065 and the duocarmycins
08/10/2005CN1653061A Process for porducing quinolonecarboxylic acid derivative
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652773A Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1651412A Amide derivative of indole, its preparation method and application
08/10/2005CN1651411A Ester derivative of indole, its preparation method and application
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1651385A High density optical disk and its compound for recording
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214007C Cyclopentanoindoles, compositions containing such compounds and methods of treatment
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927222 Compounds
08/09/2005US6926885 In-vivo diagnostic method by means of near infrared radiation
08/04/2005WO2005070886A1 Indol-alanine derivatives as selective s1p4-agonists
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005070416A1 Indirubin derivatives having anticancer property against human cancer cell me
08/04/2005WO2005069930A2 Asymmetric hydrogenation of alpha-amino carbonyl compounds
08/04/2005WO2005058819A3 Polymorphic forms of tegaserod base and salts thereof
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005037216A3 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
08/04/2005WO2005000804A3 Substituted indoles and a process for preparing substituted indoles
08/04/2005WO2004104205A3 Enzymatic preparation of chiral indole esters
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 458